founded Zymergen in April 2013. Hoffman, who was CEO, left the company last August. Dean, who was Zymergen's vice president of operations, exited last October.
Serber will receive a cash lump-sum payment equal to 12 months of his annual base salary — which was $353,485 last year — as well as his full target annual bonus. The company also will continue to pay its premium on healthcare coverage for Serber and his dependents for up to 12 months and full vesting of unvested equity awards.
Still to be worked out is what happens to Zymergen's big real estate portfolio in the East Bay, accumulated as its employee numbers ballooned in the two years prior to its implosion.
Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen: